1. CD56bright natural killer cells and response to daclizumab HYP in relapsing-remitting MS. Issue 2 (April 2015) Authors: Elkins, J.; Sheridan, J.; Amaravadi, L.; Riester, K.; Selmaj, K.; Bielekova, B.; Parr, E.; Giovannoni, G. Journal: Neurology Issue: Volume 2:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗